Top compounds associated with response to ZNF285


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.03
mRNA BIRB 0796 CTRPv2 pan-cancer AAC -0.082 0.03
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA Cerulenin CTRPv2 pan-cancer AAC -0.072 0.03
mRNA pac-1 CTRPv2 pan-cancer AAC -0.077 0.04
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.068 0.04
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.06 0.04
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.07 0.04
mRNA bid1870 gCSI pan-cancer AAC 0.12 0.04
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.066 0.05
Download CSV